This trial is testing how well low-dose radiotherapy works to treat bone pain in patients with multiple myeloma that has spread to the bone.
- Multiple Myeloma
- Bone Metastasis
1 Primary · 2 Secondary · Reporting Duration: Up to 6 months after completion of radiation therapy
1 Treatment Group
Treatment (low-dose radiation therapy)
1 of 1
100 Total Participants · 1 Treatment Group
Primary Treatment: Radiation Therapy · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
In what geographical areas is this scientific research being conducted?
"This trial is now welcoming participants at 8 distinct sites, including Boston, Los Angeles and Minneapolis. To reduce the strain of travel on yourself or your family if you decide to join this medical study, it is advised to select a site proximal to you." - Anonymous Online Contributor
Is this research endeavor currently enrolling participants?
"Affirmative. Clinicaltrials.gov documents that this clinical research is actively recruiting participants, having been initially posted on March 11th 2019 and last amended February 25th 2022. In total, 8 sites are aiming to recruit 100 individuals for the trial." - Anonymous Online Contributor
What is the present enrollment figure for this research project?
"This medical trial necessitates the enrollment of 100 qualified individuals. Patients in Boston, MA and Los Angeles, CA can access the study's resources at Dana-Farber Cancer Institute and USC / Norris Comprehensive Cancer Center respectively." - Anonymous Online Contributor